Effect of Inhaled Anesthetic Agents on Cerebral Autoregulation

Physiology of Cerebral Autoregulation (Baseline)

General Principle: Dose-Dependent Impairment

• The autoregulatory plateau narrows and shifts to the left (lower MAP threshold)
• Both the upper and lower autoregulatory breakpoints are affected
• At high enough doses, autoregulation is completely abolished, and CBF becomes pressure-passive (directly proportional to MAP)

Agent-by-Agent Comparison

1. Halothane (most potent disruptor)

• Has the greatest cerebrovascular effect of all volatile agents
• At concentrations >1 MAC (>1%), halothane nearly abolishes cerebral autoregulation
• Increases CBF by up to 200% at equivalent MAC compared to isoflurane/desflurane (~20% increase)
• Vasodilation is generalized throughout all brain regions
• CMR depression is relatively limited (≤25% maximal reduction) — less than isoflurane
• Important timing caveat for CO₂ reactivity: hyperventilation (hypocapnia) must be initiated before halothane administration to prevent increases in CBF and ICP. Simultaneous hyperventilation after halothane has already been given is less effective — in contrast to the other agents, where concurrent hyperventilation is effective.

"Halothane has the greatest effect on CBF; at concentrations greater than 1%, it nearly abolishes cerebral autoregulation."
— Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 1088

2. Isoflurane

• Causes far less cerebral vasodilation per MAC-multiple than halothane
• At 0.5 MAC: CMR suppression predominates → net decrease in CBF vs. awake state
• At 1 MAC: CMR suppression and vasodilation are balanced → CBF approximately unchanged
• >1 MAC: Direct vasodilation predominates → CBF increases significantly despite continued CMR reduction ("luxury perfusion")
• Autoregulation is attenuated at 1 MAC and progressively impaired beyond; fully abolished at high doses
• Produces the greatest maximal CMR depression of all volatile agents (up to 50%), allowing EEG burst suppression at clinically tolerated hemodynamic doses
• CO₂ reactivity preserved: hypocapnia can blunt ICP rise when initiated simultaneously
• ICP increases are mild and can be blunted by hyperventilation or barbiturate co-administration

3. Sevoflurane

• Produces the least cerebral vasodilation of the modern volatile agents
• Autoregulation preserved up to approximately 1 MAC
• At 1.5 MAC, dynamic autoregulation (rate of CBF response to rapid transient BP changes) is better preserved with sevoflurane than isoflurane
• CMR depression is similar to isoflurane and desflurane
• CO₂ vasoreactivity is preserved at 1 MAC
• ICP increases are mild (similar to isoflurane and desflurane at equivalent MAC)
• May produce EEG abnormalities (spike-wave activity) with high doses (1.5–2 MAC), especially with hypocapnia or in female patients — raises questions about use in epileptics
• PET studies confirm dose-dependent redistribution of CBF, including increased subcortical/cerebellar flow at 1.5–2 MAC

"Sevoflurane preserves autoregulation up to approximately 1 MAC. At 1.5 MAC, the dynamic rate of autoregulation is better preserved with sevoflurane than isoflurane."
— Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, p. 1415

4. Desflurane

• Cerebrovascular effects broadly similar to isoflurane and sevoflurane per MAC
• At >1 MAC: mild increases in ICP, slightly greater than isoflurane or sevoflurane in some studies
• CO₂ vasoreactivity normal up to 1.5 MAC
• Unique EEG property: desflurane-induced isoelectric EEG (at ~2 MAC in dogs) may revert to continuous activity over time despite unchanged MAC — unique to desflurane
• Airway irritant properties → administration after propofol induction can trigger increases in HR, MAP, and middle cerebral artery flow velocity — likely due to sympathetic activation rather than a direct neurophysiologic effect
• Increases CBF by ~20% at equivalent MAC vs. halothane's ~200%

5. Nitrous Oxide (N₂O)

• Acts as a direct cerebral vasodilator but causes minimal effect on CMRO2 — in sharp contrast to the potent volatile agents (which couple vasodilation to metabolic suppression)
• Effect on cerebral autoregulation is variable; some sources describe it as having a variable/uncertain effect compared to the consistent dose-dependent pattern of the potent agents
• When combined with potent volatile agents, may augment CBF increases
• Does not abolish CO₂ reactivity

Summary Comparison Table

Underlying Mechanisms

1. CMR suppression → coupled reduction in CBF (flow-metabolism coupling is maintained, not abolished)
2. Direct cerebral vasodilation → CBF increase independent of metabolism

Clinical Implications

• In elevated ICP states: prefer agents with least cerebrovascular effect; sevoflurane at ≤1 MAC is favored; halothane is contraindicated
• Hyperventilation (targeting PaCO₂ 30–35 mmHg) can blunt volatile-agent-induced CBF increases and is effective for all modern agents (isoflurane, sevoflurane, desflurane) even when used concurrently
• CBV (not CBF per se) determines ICP impact; changes in CBV are proportionally smaller than CBF changes
• Cerebral steal is possible with volatile agents in focal ischemia: increased flow to normal areas may divert blood from ischemic territories where arterioles are already maximally dilated
• All three modern potent agents (isoflurane, sevoflurane, desflurane) can be safely used with adjunctive therapies in neurosurgery, with sevoflurane generally preferred for its favorable autoregulation profile

• Morgan & Mikhail's Clinical Anesthesiology, 7e, pp. 1087–1092
• Miller's Anesthesia, 10e, pp. 1004–1020
• Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, pp. 1411–1416